Table 3:
Multivariate analysis of factors correlating with OS and LPFS
Risk factors | OS |
LPFS |
||||
---|---|---|---|---|---|---|
P-value | OR | 95% CI | P-value | OR | 95% CI | |
Agea | 0.598 | 1.0101 | 0.974–1.046 | 0.172 | 1.031 | 0.987–1.077 |
Dimensionb (<3 vs ≥3 cm) | 0.333 | 1.617 | 0.609–4.312 | 0.010 | 3.174 | 1.314–7.666 |
DFIb (<3 vs ≥3 years) | 0.206 | 0.617 | 0.292–1.304 | 0.600 | 1.296 | 0.492–3.414 |
Histologyb (colon versus other type) | 0.924 | 1.038 | 0.482–2.237 | 0.652 | 0.800 | 0.303–2.112 |
One-month LDb | 0.507 | 1.504 | 0.451–5.014 | 0.001 | 5.289 | 2.011–13.913 |
OR: odd ratio; 95% CI: 95% confidential interval; DFI: disease-free interval, defined as the time between the primary tumour and the first lung metastasis; one-month LD: presence of local disease at 1 month after RFA; OS: overall survival; LPFS: local progression-free survival; RFA: radiofrequency ablation.
aContinuous variable.
bCategorical variables.